Prime Capital Investment Advisors’s DexCom DXCM Stock Holding History

Prime Capital Investment Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,629	Closed	-$229K	–	1043
2025 Q2	$229K	Buy	+2,629	New	+$206K	﹤0.01%	849
2025 Q1	–	Sell	-2,748	Closed	-$214K	–	1078
2024 Q4	$214K	Sell	2,748 -7,002	-72%	-$518K	﹤0.01%	841
2024 Q3	$654K	Buy	+9,750	New	+$801K	0.01%	524
2024 Q2	–	Sell	-1,847	Closed	-$256K	–	954
2024 Q1	$256K	Sell	1,847 -6,030	-77%	-$758K	﹤0.01%	819
2023 Q4	$977K	Buy	7,877 +4,731	+150%	+$483K	0.01%	434
2023 Q3	$294K	Buy	+3,146	New	+$355K	0.01%	591
2023 Q2	–	Sell	-5,040	Closed	-$586K	–	772
2023 Q1	$586K	Buy	+5,040	New	+$564K	0.02%	318

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Prime Capital Investment Advisors's DXCM Position: Q3 2025 in Review

Prime Capital Investment Advisors sold out of DexCom (DXCM) in Q3 2025, closing a stake of 2,629 shares — an estimated $229K sold.

Prime Capital Investment Advisors first reported a position in DXCM in Q1 2023 and held it in 7 quarters. The position peaked at $977K in Q4 2023. 910 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

Prime Capital Investment Advisors reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
Prime Capital Investment Advisors sold 2,629 DexCom shares in Q3 2025, an estimated $229K.
Prime Capital Investment Advisors first reported a position in DexCom in Q1 2023 and held it in 7 quarters.
Prime Capital Investment Advisors's DexCom position peaked at $977K in Q4 2023.
910 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Prime Capital Investment Advisors's 13F filing for Q3 2025, filed 5 Nov 2025.